Communiqués Abbott Laboratories

Actions

ABT

US0028241000

Equipement, fournitures et distribution médicale

Marché Fermé - 22:04:06 22/09/2026 Varia. 5j. Varia. 1 janv.
103,69 USD +0,69 % Graphique intraday de Abbott Laboratories +0,58 % -17,24 %

Communiqués

17/09 Abbott declares 411th consecutive quarterly dividend PR
15/09 First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care AQ
15/09 Abbott to pay $385M over infant formula contamination probe AQ
14/09 Abbott agrees to settlement over closure of largest baby formula plant in the US AQ
14/09 Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall PR
31/08 Abbott Laboratories : Late-breaking data for Abbott’s TactiFlex™ Duo Ablation Catheter reveal positive outcomes for treating complex AFib cases PU
31/08 Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula PR
27/08 Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke PR
25/08 Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes PR
20/08 Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants PR
17/08 Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare PR
12/08 Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis PR
11/08 Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI PR
28/07 Abbott Laboratories : initiates clinical study to show outcomes for real-world use of TriClip™ in repairing leaky tricuspid heart valve PU
17/07 Army integrating new handheld device to quickly assess brain injuries AQ
16/07 Abbott Laboratories : ABT 2026 Q2 Exhibit 99.1 FINAL PU
16/07 Abbott: Q2 Earnings Snapshot AQ
16/07 Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance PR
25/06 Court Considers Whether Growth Claims Were Tall Tales AQ
25/06 Abbott hosts conference call for second-quarter earnings PR
24/06 ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing PR
23/06 New Similac(R) survey finds social media pressure to be 'perfect' is fueling a shift toward authenticity for the next generation of parents AQ
22/06 New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents PR
18/06 Big Claims, Little Kids: Recent SDNY Decision Highlights Risks In Advertising AQ
12/06 Abbott declares 410th consecutive quarterly dividend PR
Aucun résultat pour cette recherche
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇